Xylo Bio
Developer of a psychedelic therapeutic platform designed to rewire neural circuits and restore brain function. The company offers novel, non-hallucinogenic, rapid-acting medicines for psychiatric and ...
Valuation
$0
Share Price
N/A
Total Raised
$13.8M
Last Round
Unknown
Latest Funding Round
Unknown
Investors
+17 other investors